Ibm Retirement Fund Ionis Pharmaceuticals Inc Transaction History

Ibm Retirement Fund

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 12, 2021	SELL	$34.54 - $47.25 $154,117 - $210,829	-4,462 Closed	0 $0
Q1 2021 Apr 22, 2021	SELL	$42.51 - $63.78 $18,024 - $27,042	-424 Reduced 8.68%	4,462 $201,000
Q4 2020 Jan 25, 2021	BUY	$45.3 - $60.27 $28,992 - $38,572	640 Added 15.07%	4,886 $276,000
Q3 2020 Oct 16, 2020	BUY	$47.45 - $62.95 $201,472 - $267,285	4,246 New	4,246 $201,000

414

136M

862K

617K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.63B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Ibm Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on Ibm Retirement Fund with notifications on news.